Division of Livestock Infectious Diseases, State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, 427 Maduan Street, Harbin 150001, Heilongjiang, PR China.
Vet Microbiol. 2010 Nov 20;146(1-2):35-43. doi: 10.1016/j.vetmic.2010.04.016. Epub 2010 Apr 29.
Group A bovine rotaviruses (BRVs) are the most important cause of diarrheal diseases in neonatal calves and cause significant morbidity and mortality in the young animals, and epidemiologic surveillance of bovine rotavirus G genotypes conducted in various cattle populations throughout the world has shown that approximately 90% of the bovine rotavirus isolates belong to G6 and G10. Based on the modified Jennerian approach to immunization, we constructed and characterized a reassortant rotavirus stain, which bears a single bovine rotavirus VP7 gene encoding G genotype 6 specificity while the remaining 10 genes are derived from the ovine attenuated rotavirus LLR-85. The reassortant rotavirus strain, named as R191, and its parental virus strain LLR-85 were combined as bivalent vaccine candidates to inoculate the colostrums-deprived neonatal calves for evaluation of the immunogenicity. The calves were orally inoculated with the reassortant R191 (group 1), the parental rotavirus LLR-85 (group 2), or combined the R191 and LLR-85 (group 3), and serum specimens were detected to determine the immune response of IgG and IgA antibodies. Results showed that seroconversion to positivity for IgG and IgA antibodies occurred at postinoculation day (PID) 10 in all of the inoculated calves, and the highest titers of the serum IgG (range 1:800 to 1:6400) and IgA (range 1:800 to 1:3200) antibodies were obtained at PID 21 for all calves. Meanwhile, virus shedding was detected after inoculation, showing that the inoculated virus was positive in 2 of 77 fecal specimens (2.6%) collected from the inoculated calves during the first 7 days of oral inoculation with the rotavirus vaccine candidates. The results suggested that the rotavirus strains R191 and LLR-85 are promising bivalent vaccine candidates for the prevention of bovine G6 and G10 rotavirus infection.
A 组牛轮状病毒(BRV)是导致新生犊牛腹泻病的最重要原因,会导致幼畜出现严重的发病率和死亡率。对世界各地不同牛群中的牛轮状病毒 G 基因型进行的流行病学监测表明,约 90%的牛轮状病毒分离株属于 G6 和 G10。基于改良的詹纳免疫接种方法,我们构建并鉴定了一种重组轮状病毒株,该病毒株仅携带单个牛轮状病毒 VP7 基因,编码 G 基因型 6 的特异性,而其余 10 个基因则来自绵羊减毒轮状病毒 LLR-85。这种重组轮状病毒株命名为 R191,其亲本病毒株 LLR-85 被组合成二价疫苗候选物,用于接种无初乳的新生犊牛,以评估其免疫原性。将犊牛口服接种重组 R191(第 1 组)、亲本轮状病毒 LLR-85(第 2 组)或同时接种 R191 和 LLR-85(第 3 组),并检测血清样本以确定 IgG 和 IgA 抗体的免疫反应。结果表明,所有接种的犊牛在接种后第 10 天(PID)均发生 IgG 和 IgA 抗体血清阳性转化,所有犊牛在第 21 天(PID)获得最高的血清 IgG(范围 1:800 至 1:6400)和 IgA(范围 1:800 至 1:3200)抗体滴度。同时,接种后检测到病毒脱落,表明在口服接种轮状病毒疫苗候选物的前 7 天内,从接种的犊牛中采集的 77 份粪便标本中有 2 份(2.6%)检测到接种病毒呈阳性。结果表明,R191 和 LLR-85 两种轮状病毒株是预防牛 G6 和 G10 轮状病毒感染的有前途的二价疫苗候选物。